PPCB logo

PPCB
Propanc Biopharma Inc

1,308
Mkt Cap
$2.22M
Volume
554,905.00
52W High
$10.81
52W Low
$0.095
PE Ratio
-0.01
PPCB Fundamentals
Price
$0.1033
Prev Close
$0.1016
Open
$0.101
50D MA
$0.1304
Beta
0.00
Avg. Volume
6.75M
EPS (Annual)
-$14.85
P/B
0.13
Rev/Employee
$0.00
$18.38
Loading...
Loading...
News
all
press releases
Rosen Law Firm Encourages Propanc Biopharma Inc. Investors to Inquire About Securities Class Action Investigation PPCB
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Propanc Biopharma Inc. (NASDAQ: PPCB) resulting from allegations that Propanc may have issued materially misleading business information to the investing...
Business Wire·16d ago
News Placeholder
More News
News Placeholder
When Wall Street Rotates, Biotech Innovators Emerge: The Untapped Opportunities in Oncology
Market rotations are as old as Wall Street itself. When capital exits overheated sectors like big tech, it often finds its way into undervalued industries ripe for rediscovery. The latest shift, away from pricey artificial intelligence and semiconductor stocks, has once again turned investors’ attention toward biotechnology. And within biotech, the most compelling breakthroughs are not in computing or automation, but in humanity’s longest-standing battle: defeating cancer.As institutional money seeks new opportunities, healthcare and biotech have emerged as natural ...
AllPennyStocks·4mo ago
News Placeholder
When Wall Street Rotates, Biotech Innovators Emerge: The Untapped Opportunities in Oncology
Market rotations are as old as Wall Street itself. When capital exits overheated sectors like big tech, it often finds its way into undervalued industries ripe for rediscovery. The latest shift, away from pricey artificial intelligence and semiconductor stocks, has once again turned investors’ attention toward biotechnology. And within biotech, the most compelling breakthroughs are not in computing or automation, but in humanity’s longest-standing battle: defeating cancer.As institutional money seeks new opportunities, healthcare and biotech have emerged as natural ...
AllPennyStocks·4mo ago
News Placeholder
When Wall Street Rotates, Biotech Innovators Emerge: The Untapped Opportunities in Oncology
Market rotations are as old as Wall Street itself. When capital exits overheated sectors like big tech, it often finds its way into undervalued industries ripe for rediscovery. The latest shift, away from pricey artificial intelligence and semiconductor stocks, has once again turned investors’ attention toward biotechnology. And within biotech, the most compelling breakthroughs are not in computing or automation, but in humanity’s longest-standing battle: defeating cancer.As institutional money seeks new opportunities, healthcare and biotech have emerged as natural ...
AllPennyStocks·4mo ago
News Placeholder
Why Propanc stock Is Tumbling In Premarket Today
The biotech firm announced a $4 million share sale alongside its Nasdaq uplisting, sending trading volumes surging to record levels.
Stocktwits·9mo ago
<
...
1
>

Latest PPCB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.